Propeller is to enter into to a research and development collaboration with pharmaceutical manufacturer GlaxoSmithKline to test a custom sensor for the companies Ellipta inhaler for GSK . GSK will conduct a number of studies of patients with COPD , monitoring the patient's adherence remotely with help from the sensors, which will provide greater insights into how patients interact with their inhalers, and may allow for more precise correlation of adherence with safety, efficacy and economic outcomes. The sensor technology will be used to provide greater insights into adherence patterns across patient populations and may allow for more precise correlation of adherence with safety, efficacy and economic outcomes. Propeller 's monitoring system is becoming increasingly widely used in the the United States healthcare sector, with over over 35 commercial programmes covering the technology.
Propeller is to enter into to a research and development collaboration with pharmaceutical manufacturer GlaxoSmithKline to test a custom sensor for the companies Ellipta inhaler for GSK . GSK will conduct a number of studies of patients with COPD , monitoring the patient's adherence remotely with help from the sensors, which will provide greater insights into how patients interact with their inhalers, and may allow for more precise correlation of adherence with safety, efficacy and economic outcomes. Propeller 's monitoring system is becoming increasingly widely used in the the United States healthcare sector, with over over 35 commercial programmes covering the technology.